A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
On Dec. 23, molnupiravir, an investigational oral antiviral drug invented by scientists at Emory University, received Emergency Use Authorization from the FDA for the treatment of COVID-19.